Icon applies data insights to trial monitoring; Quanterix adds biomarker detection tool;

> CRO Icon has adopted a data-driven system to guide central and on-site trial monitoring. Release

> Quanterix has introduced a tool for detecting biomarkers at low concentrations. Piece

> A computer analysis of tumor samples suggests previous research may have overestimated the role of viruses in cancer. Research

> Litera has acquired clinical trial portal AxxiTRIALS. News

> Hamner Institutes has teamed up with Certara to improve modeling of drug-induced liver injury. Item

> Cresset is to add lead optimization capabilities to its drug discovery software platforms. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.